Will U.S. try to circumvent drug firms patent?

Will U.S. try to circumvent drug firms patent? : The furor over Abbott Laboratories’ 400 percent price increase last December of the AIDS drug Norvir has resulted in an unprecedented meeting at the National Institutes of Health to consider circumventing the drug giant’s patent.


Another gene genie out of the bottle

Another gene genie out of the bottle The European Commission has lifted a five-year moratorium on genetically modified produce, by allowing the sale in Europe of one type of modified corn. But the battle by producers of such crops to win governments� and consumers� acceptance is far from over


Get email updates

Get new actionable insights and updates from BiotechBlog

Biotechblog